• Ascendis Pharma A/S SVP and principal accounting officer Mads Bodenhoff sold 3,000 ordinary shares on Sept. 8, 2026 at USD 270.19.
• The sale followed the exercise of warrants for 3,000 shares at USD 110, leaving him with 0 ordinary shares.
• He reported holding 687 warrants after the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000409), on September 09, 2026, and is solely responsible for the information contained therein.